HIGHLIGHTS
- who: Naoya Otsubo from the Department of Endocrinology and Metabolism, Tokyo Metropolitan Shinjyukuu2011Ku, Tokyo, u20118488, Japan University, Tokyo, Japan have published the research work: Reduced antibody response to SARS-CoV-2 in COVID-19 patients with newly diagnosed diabetes: a retrospective observational study, in the Journal: (JOURNAL) of 28/03/2021
- what: This study demonstrated that patients with diabetes can develop IgG antibodies similar to patients without diabetes, which is consistent with the results of Lampasona V et_al As a result of the single-center design, this study had a relatively small sample size and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.